| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $82.0M | -9.4% |
| Cost of Revenue | $41.7M | +40.0% |
| Gross Profit | $40.3M | -33.7% |
| R&D Expense | $15.7M | +13.3% |
| SG&A Expense | $95.9M | -8.4% |
| Operating Income | -$78.5M | +42.8% |
| Interest Expense | $1.0M | — |
| Pre-tax Income | -$55.6M | +55.0% |
| Income Tax | -$1.0M | -17.7% |
| Net Income | -$54.6M | +35.5% |
| EPS (Basic) | -$8.33 | -1107.2% |
| EPS (Diluted) | -$8.33 | -1107.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | -68.2% |
| Accounts Receivable | $16.1M | -16.4% |
| Inventory | $17.7M | -32.4% |
| Current Assets | $56.7M | -46.3% |
| Total Assets | $70.2M | -43.3% |
| Current Liabilities | $21.1M | -60.9% |
| Long-term Debt | $10.6M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.1M | -0.6% |
| Capital Expenditures | $6.8M | -49.5% |
| Investing Cash Flow | -$7.3M | +70.8% |
| Financing Cash Flow | $24.7M | -70.1% |
| Free Cash Flow | -$58.9M | +9.7% |
| Total Liabilities |
| $86.0M |
| -18.6% |
| Stockholders' Equity | -$25.7M | -412.4% |